Reactive oxygen species and autophagy modulation in non-marine drugs and marine drugs
Ammad Ahmad Farooqi1, Sundas Fayyaz2, Ming-Feng Hou3
1Laboratory for Translational Oncology and Personalized Medicine, Rashid Latif Medical College, Lahore 54000, Pakistan. ammadfarooqi@rlmclahore.com.
Abstract:
It is becoming more understandable that an existing challenge for translational research is the development of pharmaceuticals that appropriately target reactive oxygen species (ROS)-mediated molecular networks in cancer cells. In line with this approach, there is an overwhelmingly increasing list of many non-marine drugs and marine drugs reported to be involved in inhibiting and suppressing cancer progression through ROS-mediated cell death. In this review, we describe the strategy of oxidative stress-based therapy and connect the ROS modulating effect to the regulation of apoptosis and autophagy. Finally, we focus on exploring the function and mechanism of cancer therapy by the autophagy modulators including inhibitors and inducers from non-marine drugs and marine drugs.
Insights
This review explores how targeting reactive oxygen species (ROS) with drugs can fight cancer. It examines how these drugs induce cancer cell death via apoptosis and autophagy, highlighting marine and non-marine compounds.
Area of Science:
- Oncology
- Pharmacology
- Biochemistry
Background:
- Translational research faces challenges in developing drugs targeting reactive oxygen species (ROS) in cancer.
- Numerous non-marine and marine drugs show potential in suppressing cancer progression via ROS-mediated cell death.
Purpose of the Study:
- To review oxidative stress-based cancer therapy strategies.
- To connect ROS modulation with apoptosis and autophagy regulation.
- To explore the mechanisms of autophagy modulators in cancer treatment.
Main Methods:
- Literature review of non-marine and marine drugs.
- Analysis of ROS-mediated cell death pathways.
- Examination of apoptosis and autophagy modulation in cancer.
Main Results:
- Oxidative stress-based therapy is a viable strategy for cancer treatment.
- ROS modulation influences both apoptosis and autophagy.
- Autophagy inhibitors and inducers from various drug sources show therapeutic potential.
Conclusions:
- Targeting ROS pathways offers a promising avenue for novel cancer therapeutics.
- Autophagy modulation presents a key mechanism for drug development in oncology.
- Marine and non-marine drugs provide a rich source for developing ROS-targeting cancer therapies.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Oxygen Requirements and Growth Patterns
Radical Autoxidation
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Peroxisomes
Bioactivation and Tissue Toxicity


